{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T00:23:56Z","timestamp":1718670236813},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T00:00:00Z","timestamp":1718582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T00:00:00Z","timestamp":1718582400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Xiamen Innovax Biotech Co., Ltd.","award":["XNBH00030740"],"award-info":[{"award-number":["XNBH00030740"]}]},{"name":"Jiangsu Provincial Research Hospital","award":["YJXYY202204-YSB41"],"award-info":[{"award-number":["YJXYY202204-YSB41"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Condyloma acuminata (CA) is a common, and recurrent sexually transmitted disease (STD) that greatly contributes to direct health care costs and has a substantial psychosocial impact. Human papillomavirus (HPV) vaccination (containing L1 protein for HPV types 6 and 11) effectively controls CA.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Objectives<\/jats:title>\n                <jats:p>We investigated attitudes toward the HPV vaccine for CA and willingness to undergo vaccination among STD clinic attendees in China.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Attendees at STD clinics at two selected hospitals in Guangdong and Jiangsu Provinces from May to September 2017 were requested to complete a self-administered questionnaire for this cross-sectional study.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The participants\u2019 median age was 28 years (IQR: 24.0\u201334.0), and the sex ratio was balanced; 63.5% were from Guangdong, 36.5% were from Jiangsu, and 44.5% had a history of CA. The vaccine acceptance rate was high among the participants (85.8%,235\/274) to whom the HPV vaccine for CA was available, especially among those who had heard of CA (89.0%, AOR\u2009=\u20093.14, 95% CI: 1.29\u20137.63, <jats:italic>p\u2009=<\/jats:italic>\u20090.0114). 95 (34.7%) of 274 participants had a positive attitude toward the HPV vaccine for CA. STD clinic attendees who had heard of the connection between HPV and CA (AOR\u2009=\u20092.56, 95% CI: 1.31-5.00, <jats:italic>p\u2009=<\/jats:italic>\u20090.0060), had heard of the HPV vaccines or cervical cancer vaccines (AOR\u2009=\u20091.90, 95% CI: 1.02\u20133.54, <jats:italic>p\u2009=<\/jats:italic>\u20090.0444) and had ever proactively discussed CA or the vaccine with others (AOR\u2009=\u20091.95, 95% CI:1.00-3.79, <jats:italic>p\u2009=<\/jats:italic>\u20090.0488) had better attitudes toward the HPV vaccine for CA. Over half of the participants (52.5%) expected the price of the HPV vaccine for CA to be under $90.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The acceptance of the HPV vaccine for CA was high among STD clinic attendees in China, and the participants\u2019 self-perceived knowledge of CA and HPV was associated with better attitudes toward the HPV vaccine for CA. Education to improve knowledge is vital for reducing vaccine hesitancy.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12889-024-18904-0","type":"journal-article","created":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T09:01:45Z","timestamp":1718614905000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Attitudes toward an HPV vaccine for condyloma acuminata and willingness to undergo vaccination among STD clinic attendees in China: Focus on STI prevention with HPV vaccine"],"prefix":"10.1186","volume":"24","author":[{"family":"Anqi-Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Jiali-Quan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Lingxian-Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Yue-Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Wujian-Ke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Huachun-Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Ting-Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Xuqi-Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,6,17]]},"reference":[{"issue":"2","key":"18904_CR1","doi-asserted-by":"publisher","first-page":"e180","DOI":"10.1016\/S2214-109X(19)30488-7","volume":"8","author":"C De Martel","year":"2020","unstructured":"De Martel C, Georges D, Bray F, Ferlay J, Clifford GM. Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis. Lancet Glob Health. 2020;8(2):e180\u201390. https:\/\/doi.org\/10.1016\/S2214-109X(19)30488-7.","journal-title":"Lancet Glob Health"},{"issue":"2","key":"18904_CR2","doi-asserted-by":"publisher","first-page":"e191","DOI":"10.1016\/S2214-109X(19)30482-6","volume":"8","author":"M Arbyn","year":"2020","unstructured":"Arbyn M, Weiderpass E, Bruni L, de Sanjos\u00e9 S, Saraiya M, Ferlay J, et al. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob Health. 2020;8(2):e191\u2013203. https:\/\/doi.org\/10.1016\/S2214-109X(19)30482-6.","journal-title":"Lancet Glob Health"},{"issue":"Suppl 8","key":"18904_CR3","doi-asserted-by":"publisher","first-page":"S849","DOI":"10.1093\/cid\/civ813","volume":"61","author":"IU Park","year":"2015","unstructured":"Park IU, Introcaso C, Dunne EF. Human papillomavirus and genital warts: a review of the evidence for the 2015 centers for disease control and prevention sexually transmitted diseases treatment guidelines. Clin Infect Dis. 2015;61(Suppl 8):S849\u201355. https:\/\/doi.org\/10.1093\/cid\/civ813.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"18904_CR4","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1097\/QAI.0000000000000425","volume":"68","author":"AR Giuliano","year":"2015","unstructured":"Giuliano AR, Botha MH, Zeier M, Abrahamsen ME, van der Glashoff RH, et al. High HIV, HPV, and STI prevalence among young Western Cape, South African women: EVRI HIV prevention preparedness trial. J Acquir Immune Defic Syndr. 2015;68(2):227\u201335. https:\/\/doi.org\/10.1097\/QAI.0000000000000425.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"5","key":"18904_CR5","doi-asserted-by":"publisher","first-page":"422","DOI":"10.3390\/v11050422","volume":"11","author":"JD Siqueira","year":"2019","unstructured":"Siqueira JD, Curty G, Xutao D, Hofer CB, Machado ES, Seu\u00e1nez HN, et al. Composite analysis of the virome and bacteriome of HIV\/HPV co-infected women reveals proxies for immunodeficiency. Viruses. 2019;11(5):422. https:\/\/doi.org\/10.3390\/v11050422.","journal-title":"Viruses"},{"key":"18904_CR6","doi-asserted-by":"publisher","unstructured":"Lacey CJN, Guimera N, Garland SM. Chapter 10 - low-risk human papillomavirus: genital warts, cancer and respiratory papillomatosis [M]\/\/JENKINS D, BOSCH F X. Human Papillomavirus. Acad Press. 2020;165\u201378. https:\/\/doi.org\/10.1016\/B978-0-12-814457-2.00010-6.","DOI":"10.1016\/B978-0-12-814457-2.00010-6"},{"issue":"1","key":"18904_CR7","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12879-018-3582-y","volume":"19","author":"EO Dareng","year":"2019","unstructured":"Dareng EO, Adebamowo SN, Famooto A, Olawande O, Odutola MK, Olaniyan Y, et al. Prevalence and incidence of genital warts and cervical human papillomavirus infections in Nigerian women. BMC Infect Dis. 2019;19(1):27. https:\/\/doi.org\/10.1186\/s12879-018-3582-y.","journal-title":"BMC Infect Dis"},{"key":"18904_CR8","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/1471-2334-13-39","volume":"13","author":"H Patel","year":"2013","unstructured":"Patel H, Wagner M, Singhal P, Kothari S. Systematic review of the incidence and prevalence of genital warts. BMC Infect Dis. 2013;13:39. https:\/\/doi.org\/10.1186\/1471-2334-13-39.","journal-title":"BMC Infect Dis"},{"issue":"5","key":"18904_CR9","doi-asserted-by":"publisher","first-page":"3215","DOI":"10.3760\/cma.j.issn.0412-4030.2017.05.003","volume":"50","author":"X Yue","year":"2017","unstructured":"Yue X, Gong X, Li J, Teng F, Jiang N, Men P, et al. Epidemiological features of condyloma acuminatum in national sexually transmitted disease surveillance sites in China from 2008 to 2016. Chin J Dermatol. 2017;50(5):3215. https:\/\/doi.org\/10.3760\/cma.j.issn.0412-4030.2017.05.003.","journal-title":"Chin J Dermatology"},{"issue":"1","key":"18904_CR10","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1093\/cid\/ciz168","volume":"70","author":"F Wei","year":"2020","unstructured":"Wei F, Guo M, Huang S, Li M, Cui X, Su Y, et al. Sex differences in the incidence and clearance of anogenital human papillomavirus infection in Liuzhou, China: an observational cohort study. Clin Infect Dis. 2020;70(1):82\u20139. https:\/\/doi.org\/10.1093\/cid\/ciz168.","journal-title":"Clin Infect Dis"},{"issue":"7","key":"18904_CR11","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1136\/sti.2009.037028","volume":"85","author":"M Pirotta","year":"2009","unstructured":"Pirotta M, Ung L, Stein A, Conway EL, Mast TC, Fairley CK, et al. The psychosocial burden of human papillomavirus related disease and screening interventions. Sex Transm Infect. 2009;85(7):508\u201313. https:\/\/doi.org\/10.1136\/sti.2009.037028.","journal-title":"Sex Transm Infect"},{"issue":"4","key":"18904_CR12","doi-asserted-by":"publisher","first-page":"e2022167","DOI":"10.5826\/dpc.1204a167","volume":"12","author":"MG Karaali","year":"2022","unstructured":"Karaali MG, Manav V. Evaluation of sleep quality in patients with genital and non-genital cutaneous warts: a prospective controlled study. Dermatol Pract Concept. 2022;12(4):e2022167. https:\/\/doi.org\/10.5826\/dpc.1204a167.","journal-title":"Dermatol Pract Concept"},{"key":"18904_CR13","unstructured":"WHO. Human Papillomavirus (HPV) vaccination coverage. https:\/\/immunizationdata.who.int\/global\/wiise-detail-page\/human-papillomavirus-(hpv)-vaccination-coverage?CODE=Global&YEAR. Accessed 11 April 2024."},{"issue":"7\u20138","key":"18904_CR14","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1080\/21645515.2019.1611157","volume":"15","author":"LP Wong","year":"2019","unstructured":"Wong LP, Han L, Li H, Zhao J, Zhao Q, Zimet GD. Current issues facing the introduction of human papillomavirus vaccine in China and future prospects. Hum Vaccin Immunother. 2019;15(7\u20138):1533\u201340. https:\/\/doi.org\/10.1080\/21645515.2019.1611157.","journal-title":"Hum Vaccin Immunother"},{"issue":"10","key":"18904_CR15","doi-asserted-by":"publisher","first-page":"e1335","DOI":"10.1016\/S2214-109X(20)30277-1","volume":"8","author":"Z Zou","year":"2020","unstructured":"Zou Z, Fairley CK, Ong JJ, Hocking J, Canfell K, Ma X, et al. Domestic HPV vaccine price and economic returns for cervical cancer prevention in China: a cost-effectiveness analysis. Lancet Glob Health. 2020;8(10):e1335\u201344. https:\/\/doi.org\/10.1016\/S2214-109X(20)30277-1.","journal-title":"Lancet Glob Health"},{"issue":"6","key":"18904_CR16","doi-asserted-by":"publisher","first-page":"2092363","DOI":"10.1080\/21645515.2022.2092363","volume":"18","author":"ZJ Mo","year":"2022","unstructured":"Mo ZJ, Bi ZF, Sheng W, Chen Q, Huang T, Li MQ, et al. Safety and immunogenicity of an Escherichia coli-produced bivalent human papillomavirus type 6\/11 vaccine: a dose-escalation, randomized, double-blind, placebo-controlled phase 1 trial. Hum Vaccin Immunother. 2022;18(6):2092363. https:\/\/doi.org\/10.1080\/21645515.2022.2092363.","journal-title":"Hum Vaccin Immunother"},{"issue":"6","key":"18904_CR17","doi-asserted-by":"publisher","first-page":"2776","DOI":"10.1002\/jmv.27478","volume":"94","author":"Z Dai","year":"2022","unstructured":"Dai Z, Si M, Su X, Wang W, Zhang X, Gu X, et al. Willingness to human papillomavirus (HPV) vaccination and influencing factors among male and female university students in China. J Med Virol. 2022;94(6):2776\u201386. https:\/\/doi.org\/10.1002\/jmv.27478.","journal-title":"J Med Virol"},{"issue":"1","key":"18904_CR18","doi-asserted-by":"publisher","first-page":"8763","DOI":"10.1038\/s41598-019-45258-0","volume":"9","author":"X Li","year":"2019","unstructured":"Li X, Cao X, Li Z, Yang Y, Li M, Feng B, et al. Human papillomavirus awareness and vaccine acceptability among men who have sex with men from mainland China. Sci Rep. 2019;9(1):8763. https:\/\/doi.org\/10.1038\/s41598-019-45258-0.","journal-title":"Sci Rep"},{"issue":"1","key":"18904_CR19","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3390\/vaccines8010074","volume":"8","author":"C Trucchi","year":"2020","unstructured":"Trucchi C, Amicizia D, Tafuri S, Sticchi L, Durando P, Costantino C, et al. Assessment of Knowledge, attitudes, and propensity towards HPV vaccine of young adult students in Italy. Vaccines (Basel). 2020;8(1):74. https:\/\/doi.org\/10.3390\/vaccines8010074.","journal-title":"Vaccines (Basel)"},{"issue":"6","key":"18904_CR20","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1080\/21645515.2015.1115935","volume":"12","author":"M Giuliani","year":"2016","unstructured":"Giuliani M, Vescio MF, Don\u00e0 MG, Latini A, Frasca M, Colafigli M, et al. Perceptions of human papillomavirus (HPV) infection and acceptability of HPV vaccine among men attending a sexual health clinic differ according to sexual orientation. Hum Vaccin Immunother. 2016;12(6):1542\u201350. https:\/\/doi.org\/10.1080\/21645515.2015.1115935.","journal-title":"Hum Vaccin Immunother"},{"issue":"27","key":"18904_CR21","doi-asserted-by":"publisher","first-page":"3565","DOI":"10.1016\/j.vaccine.2021.05.013","volume":"39","author":"T Nadarzynski","year":"2021","unstructured":"Nadarzynski T, Frost M, Miller D, Wheldon CW, Wiernik BM, Zou H, et al. Vaccine acceptability, uptake and completion amongst men who have sex with men: a systematic review, meta-analysis and theoretical framework. Vaccine. 2021;39(27):3565\u201381. https:\/\/doi.org\/10.1016\/j.vaccine.2021.05.013.","journal-title":"Vaccine"},{"issue":"12","key":"18904_CR22","doi-asserted-by":"publisher","first-page":"3119","DOI":"10.1080\/21645515.2020.1756151","volume":"16","author":"JD Zeitoun","year":"2020","unstructured":"Zeitoun JD, Duclos A, de Parades V, Lef\u00e8vre JH. Human papillomavirus vaccine uptake among men in France: a national time series analysis for 2015-2018. Hum Vaccin Immunother. 2020;16(12):3119\u201322. https:\/\/doi.org\/10.1080\/21645515.2020.1756151.","journal-title":"Hum Vaccin Immunother"},{"issue":"5","key":"18904_CR23","doi-asserted-by":"publisher","first-page":"486","DOI":"10.3390\/ijerph13050486","volume":"13","author":"VC Chiang","year":"2016","unstructured":"Chiang VC, Wong HT, Yeung PC, Choi YK, Fok MS, Mak OI, et al. Attitude, acceptability and knowledge of HPV vaccination among Local University Students in Hong Kong. Int J Environ Res Public Health. 2016;13(5):486. https:\/\/doi.org\/10.3390\/ijerph13050486.","journal-title":"Int J Environ Res Public Health"},{"issue":"4","key":"18904_CR24","doi-asserted-by":"publisher","first-page":"545","DOI":"10.3881\/j.issn.1000-503X.13153","volume":"43","author":"H Chen","year":"2021","unstructured":"Chen H, Zhou J, Huang Q, Si MY, Su XY, Li J. Status of human papillomavirus vaccination and knowledge, attitudes, and influencing factors towards human papillomavirus and its vaccines among University students in Western China. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2021;43(4):545\u201350. https:\/\/doi.org\/10.3881\/j.issn.1000-503X.13153. Chinese.","journal-title":"Zhongguo Yi Xue Ke Xue Yuan Xue Bao"},{"issue":"8","key":"18904_CR25","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.31557\/APJCP.2022.23.8.2719","volume":"23","author":"VK Vieira","year":"2022","unstructured":"Vieira VK, Wendt GW, Ferreto LED, Pascotto CR, Lucio LC. University students\u2019 knowledge about the relation between human papillomavirus (HPV) and head and neck and oral cancers. Asian Pac J Cancer Prev. 2022;23(8):2719\u201326. https:\/\/doi.org\/10.31557\/APJCP.2022.23.8.2719.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"2","key":"18904_CR26","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1097\/AOG.0000000000005056","volume":"141","author":"TKL Boitano","year":"2023","unstructured":"Boitano TKL, Ketch PW, Scarinci IC, Huh WK. An update on human papillomavirus vaccination in the United States. Obstet Gynecol. 2023;141(2):324\u201330. https:\/\/doi.org\/10.1097\/AOG.0000000000005056.","journal-title":"Obstet Gynecol"},{"issue":"1","key":"18904_CR27","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s10198-022-01453-x","volume":"24","author":"G Fabiano","year":"2023","unstructured":"Fabiano G, Marcellusi A, Mennini FS, Sciattella P, Favato G. Hospital resource utilisation from HPV-related diseases in England: a real-world cost analysis. Eur J Health Econ. 2023;24(1):75\u201380. https:\/\/doi.org\/10.1007\/s10198-022-01453-x.","journal-title":"Eur J Health Econ"},{"issue":"1","key":"18904_CR28","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1186\/s12913-021-07120-w","volume":"21","author":"EM Saldarriaga","year":"2021","unstructured":"Saldarriaga EM, C\u00e1rcamo CP, Babigumira JB, Garc\u00eda PJ. The annual costs of treating genital warts in the Public Healthcare Sector in Peru. BMC Health Serv Res. 2021;21(1):1092. https:\/\/doi.org\/10.1186\/s12913-021-07120-w.","journal-title":"BMC Health Serv Res"},{"issue":"1","key":"18904_CR29","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s13027-021-00403-1","volume":"16","author":"M Berrada","year":"2021","unstructured":"Berrada M, Holl R, Ndao T, Ben\u010dina G, Dikhaye S, Melhouf A, et al. Healthcare resource utilization and costs associated with anogenital warts in Morocco. Infect Agent Cancer. 2021;16(1):64. https:\/\/doi.org\/10.1186\/s13027-021-00403-1.","journal-title":"Infect Agent Cancer"},{"key":"18904_CR30","doi-asserted-by":"publisher","unstructured":"Domenech-Vi\u00f1olas M, Le\u00f3n-Maldonado L, Ram\u00edrez-Palacios P, Flores YN, Granados-Garc\u00eda V, Brown B et al. Incidence, psychosocial burden, and economic impact of genital warts in Mexico. Salud Publica Mex. 2018 Nov-Dec;60(6):624\u201332. English. https:\/\/doi.org\/10.21149\/10008.","DOI":"10.21149\/10008"},{"issue":"6","key":"18904_CR31","doi-asserted-by":"publisher","first-page":"2115267","DOI":"10.1080\/21645515.2022.2115267","volume":"18","author":"X Ren","year":"2022","unstructured":"Ren X, Qiu L, Ke W, Zou H, Liu A, Wu T. Awareness and acceptance of HPV vaccination for condyloma acuminata among men who have sex with men in China. Hum Vaccin Immunother. 2022;18(6):2115267. https:\/\/doi.org\/10.1080\/21645515.2022.2115267.","journal-title":"Hum Vaccin Immunother"},{"issue":"04","key":"18904_CR32","doi-asserted-by":"publisher","first-page":"359","DOI":"10.13735\/j.cjdv.1001-7089.202101183","volume":"35","author":"CD Association","year":"2021","unstructured":"Chinese Society of Dermatology and Venereology, Association CD. Chinese Association of Rehabilitation Dermatology and Venereology. Guideline for the Clinical Management of Anogenital Warts in China (2021) [J]. Clin J Derm. 2021;35(04):359\u201374. https:\/\/doi.org\/10.13735\/j.cjdv.1001-7089.202101183.","journal-title":"Clin J Derm"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-024-18904-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-024-18904-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-024-18904-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T09:03:14Z","timestamp":1718614994000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-024-18904-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,17]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["18904"],"URL":"https:\/\/doi.org\/10.1186\/s12889-024-18904-0","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,17]]},"assertion":[{"value":"27 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was reviewed and approved by the Ethics Committees of Guangdong Provincial Dermatology Hospital, Guangzhou, China (GDDHLS-2016112102).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"No potential conflict of interest was reported by the author(s).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"1610"}}